A Generic Review of Messenger Application: Wechat And Whatsapp
International Journal of Advanced Science Computing and Engineering · 2019
DOI: 10.30630/ijasce.1.1.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Advanced Science Computing and Engineering, 2019. Verfasst von Ewiena Bivie Anak Apon und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Over the Internet today, communication environment is more easy and interesting to the citizen. There are much interesting in modern technology when they provided a good substrate for creating large-scale data sharing, content distribution, and application-level multicast applications. The important objective of this article is getting information about comparison of two distributed system in messenger application. Messenger application is known as a tool communication that can get any information. The distributed system is one of the independent and single coherent systems it was built an application that will be informed that section is being fixed or replaces to serve more applications or users. The distributed system for this article about the comparison of two distributed system in messenger application for WeChat and Whatsapp, it is also known as the famous application for this generations nowadays.
Zitieren
APA
Apon, E. B. A., Foozy, C. F. M., & Shamala, P. (2019). A Generic Review of Messenger Application: Wechat And Whatsapp. International Journal of Advanced Science Computing and Engineering. https://doi.org/10.30630/ijasce.1.1.2
Vancouver
Apon EBA, Foozy CFM, Shamala P. A Generic Review of Messenger Application: Wechat And Whatsapp. International Journal of Advanced Science Computing and Engineering. 2019. doi:10.30630/ijasce.1.1.2
BibTeX
@article{Apon2019,
author = {Apon, Ewiena Bivie Anak and Foozy, Cik Feresa Mohd and Shamala, Palaniappan},
title = {A Generic Review of Messenger Application: Wechat And Whatsapp},
journal = {International Journal of Advanced Science Computing and Engineering},
year = {2019},
doi = {10.30630/ijasce.1.1.2}
}
EUVIMED